Published in Curr Opin Biotechnol on October 01, 2007
Reprogramming of fibroblasts into induced pluripotent stem cells with orphan nuclear receptor Esrrb. Nat Cell Biol (2009) 4.32
PU.1 and C/EBPalpha/beta convert fibroblasts into macrophage-like cells. Proc Natl Acad Sci U S A (2008) 3.35
Hematopoietic stem cell function and survival depend on c-Myc and N-Myc activity. Cell Stem Cell (2008) 2.83
Histone h3 lysine 56 acetylation is linked to the core transcriptional network in human embryonic stem cells. Mol Cell (2009) 2.27
Phenotypic correction of murine hemophilia A using an iPS cell-based therapy. Proc Natl Acad Sci U S A (2009) 2.02
Roles of Krüpel-like factor 4 in normal homeostasis, cancer and stem cells. Acta Biochim Biophys Sin (Shanghai) (2008) 1.76
Reversal of hyperglycemia in diabetic mouse models using induced-pluripotent stem (iPS)-derived pancreatic beta-like cells. Proc Natl Acad Sci U S A (2010) 1.67
Gene targeting in the rat: advances and opportunities. Trends Genet (2010) 1.25
Two factor reprogramming of human neural stem cells into pluripotency. PLoS One (2009) 1.11
Concise review: mesenchymal stem cells for diabetes. Stem Cells Transl Med (2011) 1.06
Convergent functional genomics of oligodendrocyte differentiation identifies multiple autoinhibitory signaling circuits. Mol Cell Biol (2009) 1.05
Genetic therapy for the nervous system. Hum Mol Genet (2011) 1.03
Role of epithelial-stem cell interactions during dental cell differentiation. J Biol Chem (2012) 1.02
Genome integrity: linking pluripotency and tumorgenicity. Trends Genet (2009) 1.01
A distinct role for Pin1 in the induction and maintenance of pluripotency. J Biol Chem (2011) 0.95
microRNA-17-92 cluster is a direct Nanog target and controls neural stem cell through Trp53inp1. EMBO J (2013) 0.94
A CDC20-APC/SOX2 Signaling Axis Regulates Human Glioblastoma Stem-like Cells. Cell Rep (2015) 0.94
Induced pluripotent stem cells in the study of neurological diseases. Stem Cell Res Ther (2011) 0.93
Stem cell-derived islet cells for transplantation. Curr Opin Organ Transplant (2011) 0.88
Intestinal stem cells and the colorectal cancer microenvironment. World J Gastroenterol (2014) 0.86
Challenges to the clinical application of pluripotent stem cells: towards genomic and functional stability. Genome Med (2012) 0.86
The Autism Spectrum Disorders Stem Cell Resource at Children's Hospital of Orange County: Implications for Disease Modeling and Drug Discovery. Stem Cells Transl Med (2014) 0.84
Mesenchymal and induced pluripotent stem cells: general insights and clinical perspectives. Stem Cells Cloning (2015) 0.82
Present and future cell therapies for pancreatic beta cell replenishment. World J Gastroenterol (2012) 0.81
Applications of Induced Pluripotent Stem Cells in Studying the Neurodegenerative Diseases. Stem Cells Int (2015) 0.80
Challenges for stem cells to functionally repair the damaged auditory nerve. Expert Opin Biol Ther (2012) 0.79
Critical role of Klf5 in regulating gene expression during post-eyelid opening maturation of mouse corneas. PLoS One (2012) 0.79
Cardiovascular Stem Cells in Regenerative Medicine: Ready for Prime Time? Drug Discov Today Ther Strateg (2008) 0.79
OP9 bone marrow stroma cells differentiate into megakaryocytes and platelets. PLoS One (2013) 0.78
Addiction to the IGF2-ID1-IGF2 circuit for maintenance of the breast cancer stem-like cells. Oncogene (2016) 0.77
Engineered Human Muscle Tissue from Skeletal Muscle Derived Stem Cells and Induced Pluripotent Stem Cell Derived Cardiac Cells. Int J Tissue Eng (2013) 0.76
Induced autologous stem cell transplantation for treatment of rabbit renal interstitial fibrosis. PLoS One (2013) 0.75
Complexities of X chromosome inactivation status in female human induced pluripotent stem cells-a brief review and scientific update for autism research. J Neurodev Disord (2016) 0.75
Human induced pluripotent stem cells generated neural cells behaving like brain and spinal cord cells: An insight into the involvement of retinoic acid and sonic hedgehog proteins. Int J Health Sci (Qassim) (2017) 0.75
Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell (2006) 120.51
Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell (2007) 101.42
Generation of germline-competent induced pluripotent stem cells. Nature (2007) 32.77
Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol (2007) 21.93
The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell (2003) 17.72
Generation of mouse induced pluripotent stem cells without viral vectors. Science (2008) 15.25
Generation of pluripotent stem cells from adult mouse liver and stomach cells. Science (2008) 10.55
Suppression of induced pluripotent stem cell generation by the p53-p21 pathway. Nature (2009) 9.75
A more efficient method to generate integration-free human iPS cells. Nat Methods (2011) 7.39
Nanog is the gateway to the pluripotent ground state. Cell (2009) 7.27
Retracted Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science (2004) 7.21
Induction of pluripotent stem cells from fibroblast cultures. Nat Protoc (2007) 7.01
Variation in the safety of induced pluripotent stem cell lines. Nat Biotechnol (2009) 6.39
Hypoxia enhances the generation of induced pluripotent stem cells. Cell Stem Cell (2009) 4.38
Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage. Nat Biotechnol (2011) 3.97
mTOR is essential for growth and proliferation in early mouse embryos and embryonic stem cells. Mol Cell Biol (2004) 3.72
Reactivation of the paternal X chromosome in early mouse embryos. Science (2004) 3.59
Directed and systematic differentiation of cardiovascular cells from mouse induced pluripotent stem cells. Circulation (2008) 3.11
Role of ERas in promoting tumour-like properties in mouse embryonic stem cells. Nature (2003) 3.08
Broader implications of defining standards for the pluripotency of iPSCs. Cell Stem Cell (2009) 3.03
Drug screening for ALS using patient-specific induced pluripotent stem cells. Sci Transl Med (2012) 2.80
Generation of retinal cells from mouse and human induced pluripotent stem cells. Neurosci Lett (2009) 2.75
Therapeutic potential of appropriately evaluated safe-induced pluripotent stem cells for spinal cord injury. Proc Natl Acad Sci U S A (2010) 2.52
Transcriptional repression and DNA hypermethylation of a small set of ES cell marker genes in male germline stem cells. BMC Dev Biol (2006) 2.50
Distinct signaling events downstream of mTOR cooperate to mediate the effects of amino acids and insulin on initiation factor 4E-binding proteins. Mol Cell Biol (2005) 2.47
Promotion of direct reprogramming by transformation-deficient Myc. Proc Natl Acad Sci U S A (2010) 2.44
Fbx15 is a novel target of Oct3/4 but is dispensable for embryonic stem cell self-renewal and mouse development. Mol Cell Biol (2003) 2.40
Modeling Alzheimer's disease with iPSCs reveals stress phenotypes associated with intracellular Aβ and differential drug responsiveness. Cell Stem Cell (2013) 2.32
Modeling familial Alzheimer's disease with induced pluripotent stem cells. Hum Mol Genet (2011) 2.26
An efficient nonviral method to generate integration-free human-induced pluripotent stem cells from cord blood and peripheral blood cells. Stem Cells (2013) 2.18
iPS cells: a game changer for future medicine. EMBO J (2014) 2.15
Direct reprogramming of somatic cells is promoted by maternal transcription factor Glis1. Nature (2011) 2.11
Induced pluripotent stem cells: opportunities and challenges. Philos Trans R Soc Lond B Biol Sci (2011) 2.09
Grafted human-induced pluripotent stem-cell-derived neurospheres promote motor functional recovery after spinal cord injury in mice. Proc Natl Acad Sci U S A (2011) 2.09
Transient activation of c-MYC expression is critical for efficient platelet generation from human induced pluripotent stem cells. J Exp Med (2010) 2.08
Function of IRE1 alpha in the placenta is essential for placental development and embryonic viability. Proc Natl Acad Sci U S A (2009) 2.00
Efficient and scalable purification of cardiomyocytes from human embryonic and induced pluripotent stem cells by VCAM1 surface expression. PLoS One (2011) 1.95
Generation of mouse-induced pluripotent stem cells with plasmid vectors. Nat Protoc (2010) 1.93
Model for long QT syndrome type 2 using human iPS cells demonstrates arrhythmogenic characteristics in cell culture. Dis Model Mech (2011) 1.87
Steps toward safe cell therapy using induced pluripotent stem cells. Circ Res (2013) 1.80
Donor-dependent variations in hepatic differentiation from human-induced pluripotent stem cells. Proc Natl Acad Sci U S A (2012) 1.78
miRNAs regulate SIRT1 expression during mouse embryonic stem cell differentiation and in adult mouse tissues. Aging (Albany NY) (2010) 1.76
Complete genetic correction of ips cells from Duchenne muscular dystrophy. Mol Ther (2009) 1.74
Toward the development of a global induced pluripotent stem cell library. Cell Stem Cell (2013) 1.70
New advances in iPS cell research do not obviate the need for human embryonic stem cells. Cell Stem Cell (2007) 1.68
Induced pluripotent stem cell-derived hepatocytes have the functional and proliferative capabilities needed for liver regeneration in mice. J Clin Invest (2010) 1.66
Differential membrane localization of ERas and Rheb, two Ras-related proteins involved in the phosphatidylinositol 3-kinase/mTOR pathway. J Biol Chem (2005) 1.64
Multiple functions of Jab1 are required for early embryonic development and growth potential in mice. J Biol Chem (2004) 1.58
Recent stem cell advances: induced pluripotent stem cells for disease modeling and stem cell-based regeneration. Circulation (2010) 1.54
Roles of Sall4 in the generation of pluripotent stem cells from blastocysts and fibroblasts. Genes Cells (2009) 1.53
Sirt1 plays an important role in mediating greater functionality of human ES/iPS-derived vascular endothelial cells. Atherosclerosis (2010) 1.52
Generation and characterization of human induced pluripotent stem cells. Curr Protoc Stem Cell Biol (2009) 1.50
Retraction. Science (2007) 1.48
Direct comparison of autologous and allogeneic transplantation of iPSC-derived neural cells in the brain of a non-human primate. Stem Cell Reports (2013) 1.48
Differential roles for Sox15 and Sox2 in transcriptional control in mouse embryonic stem cells. J Biol Chem (2005) 1.46
Magnesium supplementation prevents experimental chronic cyclosporine a nephrotoxicity via renin-angiotensin system independent mechanism. Transplantation (2002) 1.45
The effects of cardioactive drugs on cardiomyocytes derived from human induced pluripotent stem cells. Biochem Biophys Res Commun (2009) 1.45
In vitro pharmacologic testing using human induced pluripotent stem cell-derived cardiomyocytes. Biochem Biophys Res Commun (2009) 1.44
Adipogenic differentiation of human induced pluripotent stem cells: comparison with that of human embryonic stem cells. FEBS Lett (2009) 1.43
Induction and isolation of vascular cells from human induced pluripotent stem cells--brief report. Arterioscler Thromb Vasc Biol (2009) 1.42
iPS cells: a source of cardiac regeneration. J Mol Cell Cardiol (2010) 1.42
Generation of skeletal muscle stem/progenitor cells from murine induced pluripotent stem cells. FASEB J (2010) 1.38
Aggregation of embryonic stem cells induces Nanog repression and primitive endoderm differentiation. J Cell Sci (2004) 1.38
Induced pluripotent stem cells and reprogramming: seeing the science through the hype. Nat Rev Genet (2009) 1.36
Derivation conditions impact X-inactivation status in female human induced pluripotent stem cells. Cell Stem Cell (2012) 1.35
Induced pluripotent stem cells in medicine and biology. Development (2013) 1.35
Efficient reprogramming of human and mouse primary extra-embryonic cells to pluripotent stem cells. Genes Cells (2009) 1.35
Defining developmental potency and cell lineage trajectories by expression profiling of differentiating mouse embryonic stem cells. DNA Res (2008) 1.35
Intracellular signaling pathways regulating pluripotency of embryonic stem cells. Curr Stem Cell Res Ther (2006) 1.33
Induction and enhancement of cardiac cell differentiation from mouse and human induced pluripotent stem cells with cyclosporin-A. PLoS One (2011) 1.33
Differentiation-defective phenotypes revealed by large-scale analyses of human pluripotent stem cells. Proc Natl Acad Sci U S A (2013) 1.32
Bioengineered myocardium derived from induced pluripotent stem cells improves cardiac function and attenuates cardiac remodeling following chronic myocardial infarction in rats. Stem Cells Transl Med (2012) 1.30
Human induced pluripotent stem cells on autologous feeders. PLoS One (2009) 1.28
Generation of human melanocytes from induced pluripotent stem cells. PLoS One (2011) 1.27
Generation of naive-like porcine-induced pluripotent stem cells capable of contributing to embryonic and fetal development. Stem Cells Dev (2012) 1.27
Epigenetic regulation in pluripotent stem cells: a key to breaking the epigenetic barrier. Philos Trans R Soc Lond B Biol Sci (2013) 1.26
Anti-Aβ drug screening platform using human iPS cell-derived neurons for the treatment of Alzheimer's disease. PLoS One (2011) 1.23
Cell line-dependent differentiation of induced pluripotent stem cells into cardiomyocytes in mice. Cardiovasc Res (2010) 1.21
Immunogenicity of induced pluripotent stem cells. Circ Res (2011) 1.21
Pre-evaluated safe human iPSC-derived neural stem cells promote functional recovery after spinal cord injury in common marmoset without tumorigenicity. PLoS One (2012) 1.20
Specific lectin biomarkers for isolation of human pluripotent stem cells identified through array-based glycomic analysis. Cell Res (2011) 1.17
iPS cell technologies: significance and applications to CNS regeneration and disease. Mol Brain (2014) 1.14
Maturation, not initiation, is the major roadblock during reprogramming toward pluripotency from human fibroblasts. Proc Natl Acad Sci U S A (2013) 1.14
Integration-free iPS cells engineered using human artificial chromosome vectors. PLoS One (2011) 1.13
Dnmt3a2 targets endogenous Dnmt3L to ES cell chromatin and induces regional DNA methylation. Genes Cells (2006) 1.11
Ultrastructural maturation of human-induced pluripotent stem cell-derived cardiomyocytes in a long-term culture. Circ J (2013) 1.11
Induction of primordial germ cells from mouse induced pluripotent stem cells derived from adult hepatocytes. Mol Reprod Dev (2010) 1.11
Induction of pluripotency by defined factors. Exp Cell Res (2010) 1.09
Stem cells assessed. Nat Rev Mol Cell Biol (2012) 1.05
Characterization of dendritic cells and macrophages generated by directed differentiation from mouse induced pluripotent stem cells. Stem Cells (2009) 1.04
Genome-wide DNA methylation profile of tissue-dependent and differentially methylated regions (T-DMRs) residing in mouse pluripotent stem cells. Genes Cells (2010) 1.02
Induced pluripotent stem cells from CINCA syndrome patients as a model for dissecting somatic mosaicism and drug discovery. Blood (2012) 1.01
Gingival fibroblasts as a promising source of induced pluripotent stem cells. PLoS One (2010) 0.98
To be immunogenic, or not to be: that's the iPSC question. Cell Stem Cell (2013) 0.98
Evolutionarily conserved non-AUG translation initiation in NAT1/p97/DAP5 (EIF4G2). Genomics (2005) 0.96
Transplantation of mouse induced pluripotent stem cells into the cochlea. Neuroreport (2009) 0.96
G(i)-coupled GPCR signaling controls the formation and organization of human pluripotent colonies. PLoS One (2009) 0.95
Identification and targeted disruption of the mouse gene encoding ESG1 (PH34/ECAT2/DPPA5). BMC Dev Biol (2006) 0.95
Induced pluripotent stem cells from patients with human fibrodysplasia ossificans progressiva show increased mineralization and cartilage formation. Orphanet J Rare Dis (2013) 0.94
Esg1, expressed exclusively in preimplantation embryos, germline, and embryonic stem cells, is a putative RNA-binding protein with broad RNA targets. Dev Growth Differ (2006) 0.93